NKCC2 — Drug Target
All drugs that target NKCC2 — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Phase 2 pipeline (1)
- Extended release torsemide · Sarfez Pharmaceuticals, Inc. · Loop diuretic · Cardiovascular
Torsemide is a loop diuretic that works by inhibiting the sodium-potassium-chloride cotransporter in the thick ascending limb of the loop of Henle in the kidneys.